Surfactant therapy: past, present and future (Q38117790)

29 August 2017

Surfactant therapy: past, present and future (English)

1 reference

29 August 2017

3

1 reference

29 August 2017

Christian P Speer

1

1 reference

PubMed ID

23809343

29 August 2017

David G Sweet

series ordinal

2

1 reference

29 August 2017

1 June 2013

1 reference

29 August 2017

Early Human Development

1 reference

29 August 2017

89 Suppl 1

1 reference

29 August 2017

S22-4

1 reference

History of surfactant from 1980.

29 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Neonatal respiratory distress syndrome: an inflammatory disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Very Early Surfactant Without Mandatory Ventilation in Premature Infants Treated With Early Continuous Positive Airway Pressure: A Randomized, Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

The outcome of ELBW infants treated with NCPAP and InSurE in a resource-limited institution

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Innovation in surfactant therapy I: surfactant lavage and surfactant administration by fluid bolus using minimally invasive techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Innovation in surfactant therapy II: surfactant administration by aerosolization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

A follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Immunomodulatory properties of surfactant preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

Surfactant proteins A and D in pulmonary diseases of preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-3782%2813%2970008-2

7 January 2021

10.1016/S0378-3782(13)70008-2

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23809343